FIDEC Corporation
Coral Gables, Florida, United States
Purpose
To support a clinical study to understand the impact of a birth dose of novel Oral Polio Vaccine type 2 (nOPV2) on Polio type 2 mucosal immunity when paired with a primary series of Inactivated Polio Vaccine (IPV).
Division
Global Development
Date
June 2025
Region Served
GLOBAL
Committed amount
$5,992,597
Grant topic
Polio
Duration (months)
34
Grantee location
Coral Gables, Florida, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.